Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 233 Show results per page	View Search Criteria \| Help With Results


1.		Standard Palliative Care Versus Standard Palliative Care Plus Polychemotherapy in Metastasized Malignant Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				18 to 75				Other				ADO-MM-PAL8 NCT00226473


2.		A Companion Study for Patients Enrolled in Prior/Parent Ipilimumab Studies

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Natural history/Epidemiology, Treatment				Active				16 and over				Pharmaceutical / Industry				CA184-025 NCT00162123

Last Modified: 1/14/2009 First Published: 12/1/1998


3.		Phase III Randomized Adjuvant Study of High-Dose Interferon alfa-2b Therapy in Patients With Stage II or III Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				NCI				ECOG-1697 SWOG-E1697, CALGB-500103, CAN-NCIC-ME10, COG-E1697, E1697, NCT00003641, ME10

Last Modified: 6/11/2008 First Published: 6/1/1999


4.		Phase III Randomized Study of High-Dose Aldesleukin With or Without gp100 Antigen in Patients With Locally Advanced or Metastatic Cutaneous Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				NCI, Pharmaceutical / Industry				CCCGHS-NCI-T98-0085 NCI-T98-0085, NCI-99-C-0051B, T98-0085, NCT00019682


5.		A Treatment Combination for Patients With Unresectable Stage III or Stage IV Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				Pharmaceutical / Industry				11718 NCT00111007


6.		Standard High-Dose Alpha Interferon Versus Intermittent High-Dose Alpha Interferon

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 to 70				Other				MM-ADJ-5 NCT00226408


7.		PegIntron vs IntronA in CMAJCC Stage II (EADO 2001/CMII Trial).

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 to 75				Other				9267-01 2001-034, NCT00221702


8.		Prospective and Randomized Study to Evaluate Interest of Ultracision Use in Inguinal Lymph Nodes Curage

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				Other				05 DIVE 03 NCT00224744


9.		Tumor Infiltrating Lymphocytes Adjuvant Therapy of Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				Under 75				Other				BRD/04/1-D NCT00200577

Last Modified: 12/9/2008 First Published: 5/5/2006


10.		Phase III Randomized Study of Percutaneous Isolated Hepatic Arterial Perfusion With Melphalan With Subsequent Venous Hemofiltration Versus Best Alternative Standard Treatment in Patients With Unresectable Liver Metastases Secondary to Ocular or Cutaneous Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				NCI				NCI-06-C-0088 NCI-P6701, NCT00324727

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute